Specific parameters of the thromboelastographic profile of patients with COVID-19 in the intensive care unit
https://doi.org/10.21292/2078-5658-2020-17-6-39-44
Abstract
The objective: to study the hemostatic system of patients diagnosed with the novel new coronavirus infection and compare the data obtained with hemostatic system parameters in patients with advanced deep vein thrombosis/pulmonary embolism without COVID-19.
Subjects and methods. A single-center prospective study with retrospective control was conducted in Anesthesiological and Intensive Care Department No. 1 of Kuvatov State Medical University (Ufa) in April - May 2020, the objective of the study was to investigate the hemostatic system of patients with confirmed new coronavirus infection, patients diagnosed with venous thrombosis in 2012-2014, and a group of healthy volunteers.
Results. Evaluation of the hemostasis system in patients with thrombosis and patients with COVID-19 demonstrates the same type of changes: MA, Angle, G indices increase according to thromboelastography results, as well as D-dimer and fibrinogen levels increase, while antithrombin III activity decreases.
Conclusion. Thus, TAG may be crucial for accurate identification of patients with advanced increased risk of thrombosis and thus possibly avoid unnecessary anticoagulation in patients at low risk of thrombosis.
About the Authors
A. V. Samorodov
Bashkirsky State Medical University
Russian Federation
Russian Federation
Aleksandr V. Samorodov Doctor of Medical Sciences, Associate Professor of Anesthesiology and Intensive Care Department with Professional Development Training
3, Lenina St., Ufa, 450003
K. n Zolotukhin
Bashkirsky State Medical University
Russian Federation
Russian Federation
Konstantin N. Zolotukhin Candidate of Medical Sciences, Associate Professor of Anesthesiology and Intensive Care Department with Professional Development Training
3, Lenina St., Ufa, 450003
D. V. Zabolotskiy
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Dmitriy V. Zabolotskiy Doctor of Medical Sciences, Professor, Head of Pediatric Anesthesiology,
Intensive and Emergency Care Department Named after V.I. Gordeev
2, Litovskaya St., St. Petersburg, 194100
Yu. S. Аleksandrovich
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Yury S. Аleksandrovich Doctor of Medical Sciences, Professor, Head of Pediatric Anesthesiology, Intensive and Emergency Care Department within Professional Development Unit
2, Litovskaya St., St. Petersburg, 194100
L. I. Bashirova
Bashkirsky State Medical University
Russian Federation
Russian Federation
Linara I. Bashirova Assistant of Pharmacology Department with Training in Clinical Pharmacology
3, Lenina St., Ufa, 450003
References
1. Bakirov B.А., Sakhautdinova I.V., Maron А.D. Parameters of the hemostasis system in pregnant women with a complicated obstetric history. Kreativnaya Khirurgiya i Onkologiya, 2018, vol. 8, no. 2, pp. 125-129. (In Russ.) https://doi.org/10.24060/2076-3093-2018-8-2-41-45.
2. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (COVID-19). [Provisional guidelines on prevention, diagnostics and treatment of the new coronavirus infection (COVID-19)]. Version no. 4. (27.03.2020). https://base.garant.ru/73812452.
3. Gomzikova M.O., Gayfullina R.F., Mustafin I.G. et al. Membrane microvesicles: biological properties and involvement in the pathogenesis of diseases. Geny I Kletki, 2013, vol. 8, no. 1, pp. 6-11. (In Russ.) https://genescells.ru/article/membrannyie-mikrovezikulyi-biologicheskie-svoystva-i-uchastie-v-patogeneze-zabolevaniy.
4. Gritsenko T.А., Kosyakova Yu.А., Davydkin I.L., Danilova O.E., Krivova S.P., Kuzmina T.P., Kudlay D.А., Kurtov I.V., Naumova K.V., Osadchuk А.M., Rogozina L.А., Stepanova T.Yu., Fedorova O.I., Khayretdinov R.K. Bolezni krovi v ambulatornoy praktike. [Blood diseases in outpatient practice]. I.L. Davydkin, eds., Moscow, GEOTAR-Media Publ., 2020, 272 p. DOI:10/33029/9704-5916-4-НЕМ-2020-1-272.
5. Zolotukhin K.N., Kryuger F., Samorodov А.V. Low antithrombin III levels as a predictor of thrombotic complications in surgical patients. Kreativnaya Khirurgiya i Onkologiya, 2018, vol. 8, no. 1, pp. 52-56. (In Russ.) https://doi.org/10.24060/2076-3093-2018-8-1-52-56.
6. Ivanov D.O., Аlekandrovich Yu.S., Orel V.I. et al. Coronavirus pandemic: challenge and response to higher medical education. Pediatr, 2020, vol. 11, no. 3, pp. 5-12. (In Russ.) doi: 10.17816/PED1135-12.
7. Starshinova А.А., Kushnareva E.А., Malkova А.M., Dovgalyuk I.F., Kudlay D.А. New coronavirus infection: specific parameters of the clinical course, diagnosis opportunities, treatment and prevention of the infection in adults and children. Voprosy Sovremennoy Pediatrii, 2020, vol. 19, pp. 123-131. (In Russ.)
8. Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med., 2020, vol. 383, no. 2, pp. 120-128. DOI:10.1056 / NEJMoa2015432.
9. Bucciarelli P., Martinelli I., Artoni A. et al. Circulating microparticles and risk of venous thromboembolism. Thromb. Res., 2012, vol. 129, pp. 591-597. doi: 10.1016/j.thromres.2011.08.020.
10. Dolhnikoff M., Duarte-Neto A.N., de Almeida Monteiro R.A. et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J. Thromb. Haemost., 2020, vol. 18, no. 6, pp. 1517-1519. doi: 10.1111/jth.14844.
11. González-Castroa A., Escudero-Achaa P., Penasco Y., Leizaola O. et al. Intensive care during the 2019-coronavirus epidemic. Med. Intens., 2020, vol. 44, no. 6, pp. 351-362. doi: 10.1016/j.medine.2020.06.001.
12. Helms J., Tacquard C., Severac F. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intens. Care Med., 2020, vol. 1, pp. 10, DOI:10.1007/s00134-020-06062-x.
13. Klok F.A., Kruip M.H., van der Meer N.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res., 2020, vol. 191, pp. 145-147. doi: 10.1016 / j.2020.04.013.S. 0049-3848(20)30120-1.
14. Middeldorp S., Coppens M., van Haaps T.F. et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost., 2020, vol. 18, no. 8, pp. 1995-2002. doi: 10.1111/jth.14888.
15. Podoplelova N.A., Sveshnikova A.N., Kotova Y.N. et al. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting. Blood, 2016, vol. 128, pp. 1745‒1755. https://doi.org/10.1182/blood-2016-02-696898.
16. Tang N., Li D., Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost., 2020, vol. 18, no. 4, pp. 844-847. doi: 10.1111/jth.14768.
17. Thomas W., Samama C.M., Greinacher A. et al. Subcommittee on Perioperative and Critical Care. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH. J. Thromb. Haemost., 2018, vol. 16, pp. 2336-2340. doi: 10.1111/jth.14265.
18. Vazquez-Garza E., Jerjes-Sanchez C., Navarrete A. et al. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J. Thromb. Thrombolysis, 2017, vol. 44, pp. 377-385. doi: 10.1007/s11239-017-1528-7.
19. Wichmann D., Sperhake J.P., Lütgehetmann M. et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med., 2020, vol. 173, no. 4, pp. 268-277. doi: 10.7326/M20-2003.
Review
For citations:
Samorodov A.V., Zolotukhin K.n., Zabolotskiy D.V., Аleksandrovich Yu.S., Bashirova L.I. Specific parameters of the thromboelastographic profile of patients with COVID-19 in the intensive care unit. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2020;17(6):39-44. (In Russ.) https://doi.org/10.21292/2078-5658-2020-17-6-39-44
Email this article 